Defining the role of ubiquitination in the regulation of lipid droplets
定义泛素化在脂滴调节中的作用
基本信息
- 批准号:8911916
- 负责人:
- 金额:$ 6.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-01 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdipocytesAffinityAtherosclerosisAwardBiochemicalBiochemistryBiologicalBiological AssayBiologyCardiovascular DiseasesCell physiologyCellsCellular biologyCollaborationsComplexCoupledCytoplasmic OrganelleDataDevelopmentDiabetes MellitusDiseaseEndoplasmic ReticulumEnergy MetabolismEnvironmentEnzymesEpidemicEssential Fatty AcidsEukaryotic CellFatty AcidsFatty LiverFatty acid glycerol estersFoundationsGoalsGrantGrowthHealthHydrolysisImmunoblot AnalysisInstitutesLeadLinkLipidsLipodystrophyLipolysisMapsMeasurementMeasuresMediatingMembraneMentorsMentorshipMetabolicMetabolic ControlMetabolic DiseasesMethodologyMolecularMultiprotein ComplexesObesityOrganellesPathway interactionsPeptidesPhasePhospholipidsPhysiologic pulsePositioning AttributePost-Translational Protein ProcessingProcessProteinsProteomeProteomicsRNA InterferenceRegulationResearchResearch PersonnelResearch TrainingRoleSignal TransductionSucroseSystemTechniquesTestingTrainingTriglyceridesUbiquitinUbiquitinationUniversitiesWorkabstractingbasecareercareer developmentcombatdesignexperiencehuman diseaseinnovationlipid metabolismmonolayernovel therapeuticsoverexpressionp97 ATPaseprogramsprotein complexprotein degradationresponsesensor
项目摘要
Project Summary / Abstract
In order to develop novel therapeutic strategies to combat the increasing epidemic of metabolic diseases (eg.
obesity, diabetes, and hepatic steatosis) an in-depth understanding of the molecular mechanisms underlying
the storage and mobilization of fat is critical. In cells, fat is stored as triacylglycerol in lipid droplets (LDs), an
endoplasmic reticulum-derived organelle composed of a neutral lipid core encircled by a phospholipid
monolayer decorated with embedded proteins. Despite the clear importance of the LD proteome in controlling
LD function, the mechanisms involved in regulating their activities and levels are poorly understood.
Posttranslational conjugation with ubiquitin, which occurs via an enzymatic cascade involving an E1, E2, and
E3 enzyme, regulates virtually every cellular process. Our preliminary findings identify a metabolically
regulated LD ubiquitination pathway that involves UBXD8-mediated recruitment of p97/VCP and regulation LD
turnover catalyzed by ATGL, the rate-limiting enzyme in lipolysis. These preliminary data establish the
functional importance of this pathway in LD biology and provide a foundation for further mechanistic studies.
The studies described in this application are designed to test the hypothesis that UBXD8 functions as a sensor
for fatty acids that stabilizes LDs in response to metabolic signals by targeting the enzymes required for
lipolysis for Ub-dependent silencing. Specifically, the studies proposed in this grant will elucidate the
mechanism of UBXD8-mediated inhibition of ATGL function (Aim 1), will construct a comprehensive map of the
LD-associated ubiquitination networks (Aim 2), and will identify LD ubiquitination targets and their regulation by
the metabolic state of the cell (Aim 3).
I have extensive experience in the application of cell biology and biochemistry approaches to
understand the role of the ubiquitin system in various aspects of cellular protein quality and quantity control.
As a postdoctoral scholar I have expanded my research training to include systems-level strategies,
quantitative proteomics methodologies, and LD functional assays. During the mentored K99 phase of this
award I will work closely with my mentors Dr. Ron Kopito and Dr. Robert Farese Jr., recognized experts in the
fields of ubiquitin biology and lipid metabolism, to perform the proposed research and to implement my
research and career plan. Under their mentorship I will benefit from the combined environments of Stanford
University and the Gladstone Institute of Cardiovascular Disease, which together provide an environment rich
with opportunities for experimental training, intellectual growth, collaborations, networking, career
development, and innovative research. My short-term goal is to obtain a position as an independent
investigator, and during the R00 period of the award I will develop a robust and original research program
focused on the contribution of ubiquitin to LD function in health and disease. My long-term goal is to function
as a scientific leader and mentor to promote pioneering research that advances the fundamental
understanding of the molecular mechanisms regulating lipid metabolism and that ultimately leads to the
successful development and implementation of efficacious strategies to treat metabolic diseases.
项目摘要 /摘要
为了制定新型的治疗策略,以打击代谢疾病的日益流行(例如。
肥胖,糖尿病和肝脂肪变性)对分子机制的深入了解
脂肪的存储和动员至关重要。在细胞中,脂肪被储存为三酰基甘油中的脂肪液滴(LDS)
内质网源性细胞器,由磷脂包围的中性脂质芯组成
单层装饰有嵌入式蛋白质。尽管LD蛋白质组在控制中显然很重要
LD功能,调节其活动和水平的机制知之甚少。
翻译后与泛素结合,这是通过涉及E1,E2和
E3酶,几乎调节每个细胞过程。我们的初步发现在代谢上确定
涉及UBXD8介导的P97/VCP募集和调节LD的调节LD泛素化途径
营业额由ATGL催化,ATGL是脂解的限速酶。这些初步数据建立了
该途径在LD生物学中的功能重要性,并为进一步的机械研究提供了基础。
本应用中描述的研究旨在检验UBXD8作为传感器的假设
对于脂肪酸,可以通过靶向对代谢信号稳定LDS的脂肪酸。
脂解,用于UB依赖性沉默。具体而言,本赠款中提出的研究将阐明
UBXD8介导的ATGL功能的抑制机制(AIM 1)将构建一张综合图
与LD相关的泛素化网络(AIM 2),并将通过
细胞的代谢状态(AIM 3)。
我在细胞生物学和生物化学方法的应用方面有丰富的经验
了解泛素系统在细胞蛋白质质量和数量控制的各个方面的作用。
作为博士后学者,我将研究培训扩展到包括系统级策略,
定量蛋白质组学方法和LD功能测定。在指导的K99阶段
奖项我将与我的导师Ron Kopito博士和小罗伯特·法雷斯博士紧密合作,这是公认的专家
泛素生物学和脂质代谢领域,进行拟议的研究并实施我
研究和职业计划。在他们的指导下,我将从斯坦福的联合环境中受益
大学和格拉德斯通心血管疾病研究所,共同提供富裕的环境
有实验培训,智力增长,合作,网络,职业的机会
开发和创新研究。我的短期目标是获得独立的职位
调查员,在奖励的R00期间,我将制定一个强大而原始的研究计划
专注于泛素对LD功能在健康和疾病中的贡献。我的长期目标是运作
作为促进开拓性研究的科学领导者和导师
了解调节脂质代谢的分子机制,并最终导致
成功开发和实施有效治疗代谢疾病的策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES A OLZMANN其他文献
JAMES A OLZMANN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES A OLZMANN', 18)}}的其他基金
Leveraging evolutionary adaptations to uncover mechanisms of oxidative stress resistance
利用进化适应揭示氧化应激抵抗机制
- 批准号:
10785198 - 财政年份:2023
- 资助金额:
$ 6.27万 - 项目类别:
Global identification of endogenous ERAD substrates
内源性 ERAD 底物的整体鉴定
- 批准号:
9365628 - 财政年份:2017
- 资助金额:
$ 6.27万 - 项目类别:
Elucidating the relationship between lipid droplets, lipid metabolism, and lipotoxicity
阐明脂滴、脂质代谢和脂毒性之间的关系
- 批准号:
10293607 - 财政年份:2014
- 资助金额:
$ 6.27万 - 项目类别:
Elucidating the relationship between lipid droplets, lipid metabolism, and lipotoxicity
阐明脂滴、脂质代谢和脂毒性之间的关系
- 批准号:
10531557 - 财政年份:2014
- 资助金额:
$ 6.27万 - 项目类别:
Defining the role of ubiquitination in the regulation of lipid droplets
定义泛素化在脂滴调节中的作用
- 批准号:
8728226 - 财政年份:2013
- 资助金额:
$ 6.27万 - 项目类别:
Defining the role of ubiquitination in the regulation of lipid droplets
定义泛素化在脂滴调节中的作用
- 批准号:
8706296 - 财政年份:2013
- 资助金额:
$ 6.27万 - 项目类别:
相似国自然基金
脂肪干细胞外泌体miRNA-299a-3p调控巨噬细胞Thbs1缓解脂肪组织衰老的机制研究
- 批准号:82301753
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肝细胞因子ORM2通过抑制Kupffer细胞激活改善非酒精性脂肪性肝炎的作用及机制研究
- 批准号:82300966
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
CD36/FABP4/CPT1轴介导脂肪酸转运促进白血病干细胞的维持在白血病化疗耐药中的作用及机制研究
- 批准号:82300206
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
放射后早期神经元-星形胶质细胞脂肪酸代谢耦联对正常脑组织免疫微环境的重塑及其机制研究
- 批准号:82373516
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
高原低氧上调肝脏ANGPTL4基因的表达导致巨噬细胞M1/M2比例失衡从而促进肝脂肪化的机制研究
- 批准号:82360333
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
A novel role of cholesterol and SR-BI in adipocyte biology
胆固醇和 SR-BI 在脂肪细胞生物学中的新作用
- 批准号:
10733720 - 财政年份:2023
- 资助金额:
$ 6.27万 - 项目类别:
Nanobody- and mini-G protein-enabled molecular pharmacology of HCAR1
HCAR1 的纳米抗体和迷你 G 蛋白分子药理学
- 批准号:
10666999 - 财政年份:2023
- 资助金额:
$ 6.27万 - 项目类别:
Online Affinity Micro Free Flow Electrophoresis Assays for Continuous Monitoring of Biochemical Messengers
用于连续监测生化信使的在线亲和微自由流电泳分析
- 批准号:
10420769 - 财政年份:2022
- 资助金额:
$ 6.27万 - 项目类别:
Online Affinity Micro Free Flow Electrophoresis Assays for Continuous Monitoring of Biochemical Messengers
用于连续监测生化信使的在线亲和微自由流电泳分析
- 批准号:
10641748 - 财政年份:2022
- 资助金额:
$ 6.27万 - 项目类别:
Preclinical Validation of PPARg Acetylation Inhibitors for Diabetes Prevention and Treatment
PPARg 乙酰化抑制剂预防和治疗糖尿病的临床前验证
- 批准号:
10430186 - 财政年份:2021
- 资助金额:
$ 6.27万 - 项目类别: